Novel combination of serum microRNA for detecting breast cancer in the early stage

Akihiko Shimomura, Sho Shiino, Junpei Kawauchi, Satoko Takizawa, Hiromi Sakamoto, Juntaro Matsuzaki, Makiko Ono, Fumitaka Takeshita, Shumpei Niida, Chikako Shimizu, Yasuhiro Fujiwara, Takayuki Kinoshita, Kenji Tamura, Takahiro Ochiya

Research output: Contribution to journalArticle

83 Citations (Scopus)

Abstract

MicroRNA (miRNA), which are stably present in serum, have been reported to be potentially useful for detecting cancer. In the present study, we examined the expression profiles of serum miRNA in several large cohorts to identify novel miRNA that can be used to detect early stage breast cancer. We comprehensively evaluated the serum miRNA expression profiles using highly sensitive microarray analysis. A total of 1280 serum samples of breast cancer patients stored in the National Cancer Center Biobank were used. In addition, 2836 serum samples were obtained from non-cancer controls, 451 from patients with other types of cancers, and 63 from patients with non-breast benign diseases. The samples were divided into a training cohort including non-cancer controls, other cancers and breast cancer, and a test cohort including non-cancer controls and breast cancer. The training cohort was used to identify a combination of miRNA that could detect breast cancer, and the test cohort was used to validate that combination. miRNA expressions were compared between patients with breast cancer and non-breast cancer, and a combination of five miRNA (miR-1246, miR-1307-3p, miR-4634, miR-6861-5p and miR-6875-5p) was found to be able to detect breast cancer. This combination had a sensitivity of 97.3%, specificity of 82.9% and accuracy of 89.7% for breast cancer in the test cohort. In addition, this combination could detect early stage breast cancer (sensitivity of 98.0% for Tis).

Original languageEnglish
Pages (from-to)326-334
Number of pages9
JournalCancer Science
Volume107
Issue number3
DOIs
Publication statusPublished - 2016 Mar 1
Externally publishedYes

Fingerprint

MicroRNAs
Breast Neoplasms
Serum
Neoplasms
Microarray Analysis
Sensitivity and Specificity

Keywords

  • Biomarker
  • Breast cancer
  • Cancer screening
  • Liquid biopsy
  • microRNA

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Shimomura, A., Shiino, S., Kawauchi, J., Takizawa, S., Sakamoto, H., Matsuzaki, J., ... Ochiya, T. (2016). Novel combination of serum microRNA for detecting breast cancer in the early stage. Cancer Science, 107(3), 326-334. https://doi.org/10.1111/cas.12880

Novel combination of serum microRNA for detecting breast cancer in the early stage. / Shimomura, Akihiko; Shiino, Sho; Kawauchi, Junpei; Takizawa, Satoko; Sakamoto, Hiromi; Matsuzaki, Juntaro; Ono, Makiko; Takeshita, Fumitaka; Niida, Shumpei; Shimizu, Chikako; Fujiwara, Yasuhiro; Kinoshita, Takayuki; Tamura, Kenji; Ochiya, Takahiro.

In: Cancer Science, Vol. 107, No. 3, 01.03.2016, p. 326-334.

Research output: Contribution to journalArticle

Shimomura, A, Shiino, S, Kawauchi, J, Takizawa, S, Sakamoto, H, Matsuzaki, J, Ono, M, Takeshita, F, Niida, S, Shimizu, C, Fujiwara, Y, Kinoshita, T, Tamura, K & Ochiya, T 2016, 'Novel combination of serum microRNA for detecting breast cancer in the early stage', Cancer Science, vol. 107, no. 3, pp. 326-334. https://doi.org/10.1111/cas.12880
Shimomura A, Shiino S, Kawauchi J, Takizawa S, Sakamoto H, Matsuzaki J et al. Novel combination of serum microRNA for detecting breast cancer in the early stage. Cancer Science. 2016 Mar 1;107(3):326-334. https://doi.org/10.1111/cas.12880
Shimomura, Akihiko ; Shiino, Sho ; Kawauchi, Junpei ; Takizawa, Satoko ; Sakamoto, Hiromi ; Matsuzaki, Juntaro ; Ono, Makiko ; Takeshita, Fumitaka ; Niida, Shumpei ; Shimizu, Chikako ; Fujiwara, Yasuhiro ; Kinoshita, Takayuki ; Tamura, Kenji ; Ochiya, Takahiro. / Novel combination of serum microRNA for detecting breast cancer in the early stage. In: Cancer Science. 2016 ; Vol. 107, No. 3. pp. 326-334.
@article{2907ef86580b48a6bf654bc25dfd7180,
title = "Novel combination of serum microRNA for detecting breast cancer in the early stage",
abstract = "MicroRNA (miRNA), which are stably present in serum, have been reported to be potentially useful for detecting cancer. In the present study, we examined the expression profiles of serum miRNA in several large cohorts to identify novel miRNA that can be used to detect early stage breast cancer. We comprehensively evaluated the serum miRNA expression profiles using highly sensitive microarray analysis. A total of 1280 serum samples of breast cancer patients stored in the National Cancer Center Biobank were used. In addition, 2836 serum samples were obtained from non-cancer controls, 451 from patients with other types of cancers, and 63 from patients with non-breast benign diseases. The samples were divided into a training cohort including non-cancer controls, other cancers and breast cancer, and a test cohort including non-cancer controls and breast cancer. The training cohort was used to identify a combination of miRNA that could detect breast cancer, and the test cohort was used to validate that combination. miRNA expressions were compared between patients with breast cancer and non-breast cancer, and a combination of five miRNA (miR-1246, miR-1307-3p, miR-4634, miR-6861-5p and miR-6875-5p) was found to be able to detect breast cancer. This combination had a sensitivity of 97.3{\%}, specificity of 82.9{\%} and accuracy of 89.7{\%} for breast cancer in the test cohort. In addition, this combination could detect early stage breast cancer (sensitivity of 98.0{\%} for Tis).",
keywords = "Biomarker, Breast cancer, Cancer screening, Liquid biopsy, microRNA",
author = "Akihiko Shimomura and Sho Shiino and Junpei Kawauchi and Satoko Takizawa and Hiromi Sakamoto and Juntaro Matsuzaki and Makiko Ono and Fumitaka Takeshita and Shumpei Niida and Chikako Shimizu and Yasuhiro Fujiwara and Takayuki Kinoshita and Kenji Tamura and Takahiro Ochiya",
year = "2016",
month = "3",
day = "1",
doi = "10.1111/cas.12880",
language = "English",
volume = "107",
pages = "326--334",
journal = "Cancer Science",
issn = "1347-9032",
publisher = "Wiley-Blackwell",
number = "3",

}

TY - JOUR

T1 - Novel combination of serum microRNA for detecting breast cancer in the early stage

AU - Shimomura, Akihiko

AU - Shiino, Sho

AU - Kawauchi, Junpei

AU - Takizawa, Satoko

AU - Sakamoto, Hiromi

AU - Matsuzaki, Juntaro

AU - Ono, Makiko

AU - Takeshita, Fumitaka

AU - Niida, Shumpei

AU - Shimizu, Chikako

AU - Fujiwara, Yasuhiro

AU - Kinoshita, Takayuki

AU - Tamura, Kenji

AU - Ochiya, Takahiro

PY - 2016/3/1

Y1 - 2016/3/1

N2 - MicroRNA (miRNA), which are stably present in serum, have been reported to be potentially useful for detecting cancer. In the present study, we examined the expression profiles of serum miRNA in several large cohorts to identify novel miRNA that can be used to detect early stage breast cancer. We comprehensively evaluated the serum miRNA expression profiles using highly sensitive microarray analysis. A total of 1280 serum samples of breast cancer patients stored in the National Cancer Center Biobank were used. In addition, 2836 serum samples were obtained from non-cancer controls, 451 from patients with other types of cancers, and 63 from patients with non-breast benign diseases. The samples were divided into a training cohort including non-cancer controls, other cancers and breast cancer, and a test cohort including non-cancer controls and breast cancer. The training cohort was used to identify a combination of miRNA that could detect breast cancer, and the test cohort was used to validate that combination. miRNA expressions were compared between patients with breast cancer and non-breast cancer, and a combination of five miRNA (miR-1246, miR-1307-3p, miR-4634, miR-6861-5p and miR-6875-5p) was found to be able to detect breast cancer. This combination had a sensitivity of 97.3%, specificity of 82.9% and accuracy of 89.7% for breast cancer in the test cohort. In addition, this combination could detect early stage breast cancer (sensitivity of 98.0% for Tis).

AB - MicroRNA (miRNA), which are stably present in serum, have been reported to be potentially useful for detecting cancer. In the present study, we examined the expression profiles of serum miRNA in several large cohorts to identify novel miRNA that can be used to detect early stage breast cancer. We comprehensively evaluated the serum miRNA expression profiles using highly sensitive microarray analysis. A total of 1280 serum samples of breast cancer patients stored in the National Cancer Center Biobank were used. In addition, 2836 serum samples were obtained from non-cancer controls, 451 from patients with other types of cancers, and 63 from patients with non-breast benign diseases. The samples were divided into a training cohort including non-cancer controls, other cancers and breast cancer, and a test cohort including non-cancer controls and breast cancer. The training cohort was used to identify a combination of miRNA that could detect breast cancer, and the test cohort was used to validate that combination. miRNA expressions were compared between patients with breast cancer and non-breast cancer, and a combination of five miRNA (miR-1246, miR-1307-3p, miR-4634, miR-6861-5p and miR-6875-5p) was found to be able to detect breast cancer. This combination had a sensitivity of 97.3%, specificity of 82.9% and accuracy of 89.7% for breast cancer in the test cohort. In addition, this combination could detect early stage breast cancer (sensitivity of 98.0% for Tis).

KW - Biomarker

KW - Breast cancer

KW - Cancer screening

KW - Liquid biopsy

KW - microRNA

UR - http://www.scopus.com/inward/record.url?scp=84960145675&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84960145675&partnerID=8YFLogxK

U2 - 10.1111/cas.12880

DO - 10.1111/cas.12880

M3 - Article

C2 - 26749252

AN - SCOPUS:84960145675

VL - 107

SP - 326

EP - 334

JO - Cancer Science

JF - Cancer Science

SN - 1347-9032

IS - 3

ER -